These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35685309)

  • 1. Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes.
    Ling J; Ng JKCC; Lau ESH; Ma RCW; Kong APS; Luk AOY; Kwok JSS; Szeto CC; Chan JCN; Chow E
    Kidney Int Rep; 2022 Jun; 7(6):1354-1363. PubMed ID: 35685309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
    Mayeda L; Katz R; Ahmad I; Bansal N; Batacchi Z; Hirsch IB; Robinson N; Trence DL; Zelnick L; de Boer IH
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
    Oriot P; Viry C; Vandelaer A; Grigioni S; Roy M; Philips JC; Prévost G
    J Diabetes Sci Technol; 2023 Nov; 17(6):1553-1562. PubMed ID: 35466719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data.
    Chrzanowski J; Michalak A; Łosiewicz A; Kuśmierczyk H; Mianowska B; Szadkowska A; Fendler W
    Diabetes Technol Ther; 2021 Apr; 23(4):293-305. PubMed ID: 33112161
    [No Abstract]   [Full Text] [Related]  

  • 6. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
    Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
    Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
    Ling J; Ng JKC; Chan JCN; Chow E
    Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease.
    Ólafsdóttir AF; Andelin M; Saeed A; Sofizadeh S; Hamoodi H; Jansson PA; Lind M
    World J Clin Cases; 2022 Aug; 10(22):7794-7807. PubMed ID: 36158498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A View Beyond HbA1c: Role of Continuous Glucose Monitoring.
    Chehregosha H; Khamseh ME; Malek M; Hosseinpanah F; Ismail-Beigi F
    Diabetes Ther; 2019 Jun; 10(3):853-863. PubMed ID: 31037553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Jan; 16(1):113-119. PubMed ID: 33269634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes.
    Fang M; Wang D; Rooney MR; Echouffo-Tcheugui JB; Coresh J; Aurora RN; Punjabi NM; Selvin E
    Clin Chem; 2023 Apr; 69(4):422-428. PubMed ID: 36738249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
    Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD.
    Presswala L; Hong S; Harris Y; Romao I; Zhang M; Jhaveri KD; Sakhiya V; Fishbane S
    Kidney Med; 2019; 1(5):281-287. PubMed ID: 32734208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis.
    Bomholt T; Adrian T; Nørgaard K; Ranjan AG; Almdal T; Larsson A; Vadstrup M; Rix M; Feldt-Rasmussen B; Hornum M
    Nephron; 2021; 145(1):14-19. PubMed ID: 33264783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
    Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
    Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of Hyperglycemia, Hypoglycemia and Inter-Day Glucose Variability Using Continuous Glucose Monitoring among Diabetic Patients on Chronic Hemodialysis.
    Divani M; Georgianos PI; Didangelos T; Liakopoulos V; Makedou K; Iliadis F; Savopoulos C; Grekas DM
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes.
    Shah VN; Vigers T; Pyle L; Calhoun P; Bergenstal RM
    Diabetes Technol Ther; 2023 May; 25(5):324-328. PubMed ID: 36790875
    [No Abstract]   [Full Text] [Related]  

  • 20. [Impacts of glycemic variability on the relationship between time in range and estimated glycated hemoglobin in patients with type 1 diabetes mellitus].
    Peng HM; Deng HR; Zhou YW; Wang CF; Lyu J; Mai XD; Yang DZ; Lu J; Xu W; Yan JH
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1190-1195. PubMed ID: 35462500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.